Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05489237 |
|---|---|
| Brief Title: | A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST 1] |
| First Submitted : | July 28, 2022 |
| First Submitted that Met QC Criteria : | August 3, 2022 |
| First Posted : | August 5, 2022 |
| Last Update Submitted that Met QC Criteria : | April 5, 2024 |
| Last Update Posted : | April 9, 2024 |